La Jolla, CA, United States of America

Hema Rangaswami


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hema Rangaswami: Innovator in Aortic Disease Treatment

Introduction

Hema Rangaswami is a notable inventor based in La Jolla, California. She has made significant contributions to the field of medical treatment, particularly in addressing aortic diseases. Her innovative work focuses on developing effective therapies for conditions such as aortic aneurysms.

Latest Patents

Hema Rangaswami holds a patent for a treatment aimed at aortic aneurysms. The patent details compositions and methods for treating aortic disease in subjects in need, comprising an effective amount of cobinamide. Aortic diseases, including aortic aneurysm, aortic dissection, and aortic dilation, can arise from various causes such as Marfan syndrome or oxidative stress. This patent represents her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Hema Rangaswami is affiliated with the University of California, where she continues her research and development efforts. Her work has garnered attention for its potential to transform treatment protocols for aortic diseases. With a focus on innovative solutions, she has established herself as a key figure in her field.

Collaborations

Hema collaborates with esteemed colleagues, including Gerard Boss and Darren Casteel. These partnerships enhance her research capabilities and contribute to the advancement of medical treatments.

Conclusion

Hema Rangaswami's contributions to the treatment of aortic diseases highlight her role as an influential inventor. Her patent for a treatment involving cobinamide showcases her dedication to improving healthcare solutions. Through her work at the University of California and collaborations with fellow researchers, she continues to make strides in medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…